Literature DB >> 19506876

Identification of candidate genes for susceptibility to reactive arthritis.

Markus Rihl1, Christian Barthel, Andreas Klos, Reinhold E Schmidt, Paul P Tak, Henning Zeidler, Jens G Kuipers.   

Abstract

This study was undertaken to evaluate the gene expression profile in monocytes from three patients with reactive arthritis (ReA) in remission in order to identify candidate genes accounting for a potential susceptibility to ReA. Gene expression analyses revealed eight differentially expressed mRNA transcripts in monocytes of ReA patients. The major part of genes encoded cytokines, growth factors and chemokines. There was a remarkably high proportion of proangiogenic factors, in particular IP10, ENA-78, and IL-8 accounting for a genetically determined susceptibility to ReA at the host cell level.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19506876     DOI: 10.1007/s00296-009-0992-6

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  12 in total

Review 1.  Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.

Authors:  Joachim Sieper; Martin Rudwaleit; Jürgen Braun; Désirée van der Heijde
Journal:  Arthritis Rheum       Date:  2002-02

2.  Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome.

Authors:  M U Rahman; M A Cheema; H R Schumacher; A P Hudson
Journal:  Arthritis Rheum       Date:  1992-05

3.  Alpha beta but not gamma delta T cell clones in synovial fluids of patients with reactive arthritis show active transcription of tumour necrosis factor alpha and interferon gamma.

Authors:  M Rihl; J Gu; D Baeten; E Märker-Hermann; J C Goodall; J S H Gaston; J G Kuipers; H Zeidler; D T Y Yu
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

4.  Persistent infection of Chlamydia in reactive arthritis.

Authors:  M Rihl; L Köhler; A Klos; H Zeidler
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

5.  Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis.

Authors:  K Granfors; R Merilahti-Palo; R Luukkainen; T Möttönen; R Lahesmaa; P Probst; E Märker-Hermann; P Toivanen
Journal:  Arthritis Rheum       Date:  1998-05

6.  Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles.

Authors:  Jieruo Gu; Markus Rihl; Elisabeth Märker-Hermann; Dominique Baeten; Jens G Kuipers; Yeong Wook Song; Walter P Maksymowych; Ruben Burgos-Vargas; Eric M Veys; Filip De Keyser; Helmuth Deister; Momiao Xiong; Feng Huang; Wen Chan Tsai; David Tak Yan Yu
Journal:  J Rheumatol       Date:  2002-10       Impact factor: 4.666

7.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

8.  Epithelial neutrophil activating peptide-78: a novel chemotactic cytokine for neutrophils in arthritis.

Authors:  A E Koch; S L Kunkel; L A Harlow; D D Mazarakis; G K Haines; M D Burdick; R M Pope; A Walz; R M Strieter
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

Review 9.  Interleukin-6 and chronic inflammation.

Authors:  Cem Gabay
Journal:  Arthritis Res Ther       Date:  2006-07-28       Impact factor: 5.156

10.  Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes.

Authors:  Sina Schrader; Andreas Klos; Simone Hess; Henning Zeidler; Jens G Kuipers; Markus Rihl
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  1 in total

1.  Epidemiology of Clostridium difficile Infection-Associated Reactive Arthritis in Children: An Underdiagnosed, Potentially Morbid Condition.

Authors:  Daniel B Horton; Brian L Strom; Mary E Putt; Carlos D Rose; David D Sherry; Julia S Sammons
Journal:  JAMA Pediatr       Date:  2016-07-05       Impact factor: 16.193

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.